A. Awan

2.1k total citations
46 papers, 1.6k citations indexed

About

A. Awan is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, A. Awan has authored 46 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 12 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in A. Awan's work include Prostate Cancer Treatment and Research (14 papers), Prostate Cancer Diagnosis and Treatment (13 papers) and Advanced Radiotherapy Techniques (9 papers). A. Awan is often cited by papers focused on Prostate Cancer Treatment and Research (14 papers), Prostate Cancer Diagnosis and Treatment (13 papers) and Advanced Radiotherapy Techniques (9 papers). A. Awan collaborates with scholars based in United States, Denmark and United Kingdom. A. Awan's co-authors include Ralph R. Weichselbaum, Søren T. Christensen, Lotte B. Pedersen, Srinivasan Vijayakumar, Bradley K. Yoder, Iben R. Veland, Everett E. Vokes, Anne Grete Byskov, Lani Ignacio and Peter Satir and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Cell Biology.

In The Last Decade

A. Awan

45 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Awan United States 21 617 582 435 325 307 46 1.6k
Sarah McAvoy United States 17 495 0.8× 294 0.5× 284 0.7× 165 0.5× 85 0.3× 36 1.1k
Stephen H. Settle United States 15 470 0.8× 346 0.6× 201 0.5× 310 1.0× 439 1.4× 25 1.2k
Sofia Haque United States 28 747 1.2× 461 0.8× 171 0.4× 939 2.9× 478 1.6× 95 2.5k
Laëtitia Padovani France 23 564 0.9× 404 0.7× 66 0.2× 463 1.4× 132 0.4× 86 1.7k
Koichi Yoshikawa Japan 14 601 1.0× 499 0.9× 50 0.1× 518 1.6× 245 0.8× 45 1.7k
Richard J. Young Australia 25 958 1.6× 529 0.9× 109 0.3× 915 2.8× 569 1.9× 73 2.5k
Yoshihiko Yoshii Japan 24 312 0.5× 549 0.9× 103 0.2× 322 1.0× 251 0.8× 102 1.6k
Alexander Pearlman United States 16 271 0.4× 252 0.4× 286 0.7× 128 0.4× 142 0.5× 38 954
P N Plowman United Kingdom 28 482 0.8× 773 1.3× 94 0.2× 726 2.2× 955 3.1× 94 2.8k
Jason K. Molitoris United States 16 367 0.6× 325 0.6× 41 0.1× 243 0.7× 121 0.4× 111 1.1k

Countries citing papers authored by A. Awan

Since Specialization
Citations

This map shows the geographic impact of A. Awan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Awan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Awan more than expected).

Fields of papers citing papers by A. Awan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Awan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Awan. The network helps show where A. Awan may publish in the future.

Co-authorship network of co-authors of A. Awan

This figure shows the co-authorship network connecting the top 25 collaborators of A. Awan. A scholar is included among the top collaborators of A. Awan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Awan. A. Awan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Awan, A., et al.. (2025). Ubiquitination Enzymes in Cancer, Cancer Immune Evasion, and Potential Therapeutic Opportunities. Cells. 14(2). 69–69. 4 indexed citations
3.
Egeberg, Dorte L, Robert T. Manguso, Linda Schneider, et al.. (2012). Primary cilia and aberrant cell signaling in epithelial ovarian cancer. SHILAP Revista de lepidopterología. 1(1). 15–15. 74 indexed citations
4.
Fernández-L, Africa, Massimo Squatrito, Paul A. Northcott, et al.. (2011). Oncogenic YAP promotes radioresistance and genomic instability in medulloblastoma through IGF2-mediated Akt activation. Oncogene. 31(15). 1923–1937. 129 indexed citations
5.
Veland, Iben R., A. Awan, Lotte B. Pedersen, Bradley K. Yoder, & Søren T. Christensen. (2009). Primary Cilia and Signaling Pathways in Mammalian Development, Health and Disease. Nephron Physiology. 111(3). p39–p53. 215 indexed citations
6.
Awan, A., et al.. (2009). Immunoflourescence and mRNA Analysis of Human Embryonic Stem Cells (hESCs) Grown Under Feeder-Free Conditions. Methods in molecular biology. 584. 195–210. 16 indexed citations
7.
Awan, A., Aaron Bell, & Peter Satir. (2009). Kin5 Knockdown in Tetrahymena thermophila Using RNAi Blocks Cargo Transport of Gef1. PLoS ONE. 4(3). e4873–e4873. 6 indexed citations
8.
Møllgård, Kjeld, Christian Clément, Iben R. Veland, et al.. (2008). Characterization of primary cilia and Hedgehog signaling during development of the human pancreas and in human pancreatic duct cancer cell lines. Developmental Dynamics. 237(8). 2039–2052. 57 indexed citations
10.
Awan, A., Mitchell Bernstein, Toshikazu Hamasaki, & Peter Satir. (2004). Cloning and characterization of Kin5, a novel Tetrahymena ciliary kinesin II. Cell Motility and the Cytoskeleton. 58(1). 1–9. 20 indexed citations
11.
Abdalla, Ibrahim, Lani Ignacio, Florin Vaida, et al.. (2002). Evolution of toxicity after conformal radiotherapy for prostate cancer. Prostate Cancer and Prostatic Diseases. 5(4). 296–303. 12 indexed citations
12.
Jani, Ashesh B., Florin Vaida, Gerald E. Hanks, et al.. (2001). Changing face and different countenances of prostate cancer: Racial and geographic differences in prostate‐specific antigen (PSA), stage, and grade trends in the PSA era. International Journal of Cancer. 96(6). 363–371. 46 indexed citations
13.
14.
Mantz, C.A., Paul Y. Song, A. Awan, et al.. (1997). Potency probability following conformal megavoltage radiotherapy using conventional doses for localized prostate cancer. International Journal of Radiation Oncology*Biology*Physics. 37(3). 551–557. 63 indexed citations
15.
Mundt, Arno J., A. Awan, Gregory S. Sibley, et al.. (1995). Conservative surgery and adjuvant radiation therapy in the management of adult soft tissue sarcoma of the extremities: Clinical and radiobiological results. International Journal of Radiation Oncology*Biology*Physics. 32(4). 977–985. 104 indexed citations
16.
Vijayakumar, Srinivasan, A. Awan, Theodore Karrison, et al.. (1993). Acute toxicity during external-beam radiotherapy for localized prostate cancer: Comparison of different techniques. International Journal of Radiation Oncology*Biology*Physics. 25(2). 359–371. 81 indexed citations
17.
Vijayakumar, Srinivasan, Mack Roach, William M. Wara, et al.. (1993). Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: Preliminary results of a randomized, open-labeled, phase II trial. International Journal of Radiation Oncology*Biology*Physics. 26(4). 721–729. 44 indexed citations
18.
Beckett, Michael A., Srinivasan Vijayakumar, Michael A. Simon, et al.. (1990). Radiobiological characterization of head and neck and sarcoma cells derived from patients prior to radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 19(2). 313–319. 49 indexed citations
19.
Vokes, Everett E., W. R. Panje, Richard L. Schilsky, et al.. (1989). Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study.. Journal of Clinical Oncology. 7(6). 761–768. 102 indexed citations
20.
Awan, A., Jacob D. Bitran, Philip C. Hoffman, et al.. (1987). Prophylactic cranial irradiation in adenocarcinoma of the lung a possible role. Cancer. 59(12). 2016–2019. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026